{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:49:30Z","timestamp":1792046970265,"version":"4.4.0"},"reference-count":93,"publisher":"Wiley","issue":"20","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FEBS Journal"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>\n                    Diabetes mellitus (DM) is a metabolic disease characterised by chronic hyperglycemia. The Glucagon\u2010Like Peptide\u20101 Receptor Agonists (GLP\u20101 RAs) used in type 2 diabetes mellitus (T2DM) have been highlighted for their potential benefits to the gut microbiota in the context of this pathology. Therefore, it is important to investigate the relationship between microbiota and GLP\u20101 RAs used in T2DM. This review aimed at evaluating the effects of GLP\u20101 agonists on gut microbiota in T2DM individuals. The protocol was previously registered in PROSPERO, and the search was conducted in PubMed, Scopus, Web of Science, and Embase databases in March 2025. Two reviewers have read the titles and abstracts and selected the included articles based on established criteria. The initial search identified 5532 publications, of which 17 studies were included: 12 preclinical and 5 clinical. Most were conducted in China between 2016 and 2025. GLP\u20101 agonists have been shown to modulate the gut microbiota, characterised by an increase in Bacteroidetes,\n                    <jats:italic>Akkermansia muciniphila<\/jats:italic>\n                    , and\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    . These changes are accompanied by an improvement of intestinal villi, increase in occludin expression, as well as an improvement in colonic inflammation. We identified a higher abundance of bacterial species associated with intestinal balance (eubiosis), accompanied by reduced inflammation and insulin resistance. Conversely, there was a lower abundance of bacteria related to dysbiosis, such as\n                    <jats:italic>Firmicutes<\/jats:italic>\n                    and\n                    <jats:italic>Proteobacteria<\/jats:italic>\n                    , which can be unfavourable when in excess. GLP\u20101 agonists influence the intestinal microbiota, improving metabolic parameters and anti\u2010inflammatory effects. However, further clinical studies are needed to corroborate the findings of this review.\n                  <\/jats:p>","DOI":"10.1111\/febs.70656","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:51:06Z","timestamp":1787291466000},"page":"5971-5995","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of\n                    <scp>GLP<\/scp>\n                    \u20101 agonists on the gut microbiota in type 2 diabetes mellitus: a systematic review"],"prefix":"10.1111","volume":"293","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4437-2898","authenticated-orcid":false,"given":"Ranicleide","family":"Santos Dantas","sequence":"first","affiliation":[{"name":"Department of Pharmacy Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Vin\u00edcius","family":"Souza Santos","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Gustavo","family":"Carvalho de Oliveira","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-0688","authenticated-orcid":false,"given":"Marina","family":"dos Santos Barreto","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Pharmaceutical Sciences Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deise Maria","family":"Rego Rodrigues Silva","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Pharmaceutical Sciences Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique","family":"Macedo Moura","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Pharmaceutical Sciences Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloia Emanuelly","family":"Dias Silva","sequence":"additional","affiliation":[{"name":"Northeast Biotechnology Network (RENORBIO) Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldy","family":"Santana Santos","sequence":"additional","affiliation":[{"name":"Postgraduate Pharmacy Program (Pathophysiology and Toxicology) University of S\u00e3o Paulo  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Alves da Mota Santana","sequence":"additional","affiliation":[{"name":"School of Dentistry Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gandhi Gopalsamy","sequence":"additional","affiliation":[{"name":"Division of Phytochemistry and Drug Design, Department of Biosciences Rajagiri College of Social Sciences  Kochi Kerala India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Gibara Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Federal University of Sergipe  Brazil"},{"name":"Postgraduate Program in Pharmaceutical Sciences Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-1547","authenticated-orcid":false,"given":"Lysandro","family":"Pinto Borges","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Federal University of Sergipe  Brazil"},{"name":"Postgraduate Program in Pharmaceutical Sciences Federal University of Sergipe  Brazil"},{"name":"Northeast Biotechnology Network (RENORBIO) Federal University of Sergipe  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"PereiraLRP(2017)A preval\u00eancia do Diabetes Mellitus tipo 2 em adultos jovens de uma Unidade de Sa\u00fade."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu16223951"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-019-1450-4"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.102037"},{"key":"e_1_2_11_7_1","unstructured":"De Oliveira(2025)Revista novos desafios."},{"key":"e_1_2_11_8_1","volume-title":"Diabetes Atlas","author":"Magliano D","year":"2025"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu17081303"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10102061"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88612-x"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-021-00446-0"},{"key":"e_1_2_11_13_1","unstructured":"PenfornistemA BorottemS&RaccahbDAbordagem terap\u00eautica do diabetes mellitus tipo 2."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu8040202"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.34119\/bjhrv4n1-263"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177827"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871530316666160831093813"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S418757"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11128"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.879294"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.416"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2022.856661"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/db19-999-P"},{"key":"e_1_2_11_24_1","volume-title":"Semaglutide Modulated the Gut Microbiome Composition and Improved Bile Acid Profiles in a Mouse Model of Diabetic Nephropathy","author":"Kang H","year":"2024"},{"key":"e_1_2_11_25_1","volume-title":"GLP\u20101 Receptor Agonist Impact Gut Microbiota and Intestinal Immunity to Improve Hyperglycaemia and Dyslipidaemia in Rodents","author":"Burcelin R","year":"2017"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034978"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109784"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep33251"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00233"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27343"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217743765"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118457"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01657-8"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110339"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149882"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123310"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-024-10142-w"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17055"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113937"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.9"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2021.101223"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.814770"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-36318-3"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-023-01277-3"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-2194-9"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep32165"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13036-1"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.30802\/AALAS-JAALAS-24-127"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8010134"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43"},{"key":"e_1_2_11_51_1","unstructured":"ROBINS\u2010I|Vi\u00e9s Cochrane Cochrane Bias Methods Group(2026)ROBINS\u2010I: Risk Of Bias In Non\u2010randomized Studies \u2013 of Interventions. Available at: Cochrane ROBINS\u2010I (accessed 26 June 2026)."},{"key":"e_1_2_11_52_1","unstructured":"20190822_RoB_2.0_guidance_parallel_trial HigginsJPT Savovi\u0107J PageMJ ElbersRG&SterneJAC(2019)Revised Cochrane risk\u2010of\u2010bias tool for randomized trials (RoB 2): guidance document for parallel\u2010group trials."},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144933"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.11.051"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250855"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.76201"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.26442\/20751753.2024.4.202736"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i43.4682"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S451129"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105420"},{"key":"e_1_2_11_61_1","unstructured":"CuiJ RameshG WuM JensenET CragoO BertoniAG GaoC HoffmanKL SheridanPA WongKEet\u00a0al.Bact\u00e9rias produtoras de butirato e homeostase da insulina: o estudo de avalia\u00e7\u00e3o longitudinal do microbioma e da insulina (MILES)."},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2019.01.021"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf167"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.09.007"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2018.07.009"},{"key":"e_1_2_11_66_1","unstructured":"TononCRInflu\u00eancia de an\u00e1logo de GLP\u20101 na microbiota intestinal e atenua\u00e7\u00e3o da cardiotoxicidade induzida pela doxorrubicina em ratos."},{"key":"e_1_2_11_67_1","article-title":"Differences in gut microbiota modulation by Semaglutide, Liraglutide and Tirzepatide","volume":"2","author":"Nowakowska J","year":"2025","journal-title":"Int J Innov Technol Soc Sci"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189936"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176440"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17891"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03799-0"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1715024"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu17152516"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030562"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-022-00526-0"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf351"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70510"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01603-y"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1042189"},{"key":"e_1_2_11_80_1","unstructured":"TanakaH NakamuraY FujimotoA SatoK&SuzukiMPrausnitzii e Roseburia spp."},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1677671"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106320"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1508"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-025-01486-8"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1399632"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15611"},{"key":"e_1_2_11_87_1","article-title":"GLP\u20101 receptor agonists and delayed gastric emptying: implications for invasive cardiac interventions and surgery","volume":"14","author":"Shankar A","year":"2024","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.08.003"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.53469\/wjimt.2024.07(06).23"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/life15060843"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_11_92_1","unstructured":"(2016)NIST Guide to the SI Appendix B: Conversion Factors."},{"key":"e_1_2_11_93_1","unstructured":"WebPlotDigitizer version 5.3. Available at:https:\/\/automeris.io\/WebPlotDigitizer(accessed 26 June 2026)"},{"key":"e_1_2_11_94_1","unstructured":"GRADEpro GDT(https:\/\/gdt.gradepro.org\/app\/) (2026)GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime."}],"container-title":["The FEBS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/febs.70656","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/febs.70656","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/febs.70656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:34:10Z","timestamp":1792046050000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/febs.70656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":93,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/febs.70656"],"URL":"https:\/\/doi.org\/10.1111\/febs.70656","archive":["Portico"],"relation":{},"ISSN":["1742-464X","1742-4658"],"issn-type":[{"value":"1742-464X","type":"print"},{"value":"1742-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"2025-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}